The North America Kyphoplasty Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).
The kyphoplasty surgery can enhance mobility & alignment while reducing pain. This can lead to a marked improvement in general quality of life combined with less dependence on narcotic painkillers. Kyphoplasty also provides the added benefit of enhancing or restoring mechanical alignment and vertebral body height at the fracture location. Compression fractures can cause kyphosis and height loss, which can lower pulmonary function and negatively impact the quality of life. Procedures for kyphoplasty are reliable, minimally invasive, and safe. When people are treated utilizing this method, they offer pain alleviation and fracture stability.
A large number of fractures have undergone balloon kyphoplasty surgery in the past decades. In clinical investigations, balloon kyphoplasty has shown to restore vertebral body height & improve vertebral body deformities when compared to non-surgical methods. Further, this method is superior to others due to enhanced quality of life, mobility, and the ability to do everyday tasks, which in turn encourages market expansion.
North America is expecting high demand for kyphoplasty procedures due to the region's ageing population and product approvals. In the elderly population, spinal compression fractures are frequently observed. The American Association of Neurological Surgeons states that elderly women are more likely than older men to experience a spinal compression fracture. Recently, the US FDA (Food & Drug Administration) approved Cardinal Health's "Ava-Tex Radiopaque Bone Cement," which may be used in operations to treat spine fractures. Such initiatives might encourage the market under study to increase usage and demand for these methods. The regional healthcare industry's expansion is accelerating the market for kyphoplasty.
The US market dominated the North America Kyphoplasty Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $226.7 million by 2028. The Canada market is poised to grow at a CAGR of 8.1% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.2% during (2022 - 2028).
Based on Product Type, the market is segmented into Accessories and Kyphoplasty Systems. Based on Indication, the market is segmented into Osteoporosis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Kyphoplasty Market is Estimated to reach $837.1 Million by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.
By Product Type
By Indication
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
